SANDERLING MANAGEMENT COMPANY, LLC
CRD #162520 SEC #802-76069 SAN MATEO, CA 650 401 2000
State Registered Exempt Reporting Private Funds
Total AUM
--
Discretionary
--
Employees
--
Clients
--
Accounts
--
| Fund Name | Type | GAV | Investors | Auditor |
|---|---|---|---|---|
| SANDERLING VENTURE PARTNERS VI, L.P. | Venture Capital Fund | $314.3M | 72 | ROTHSTEIN KASS |
| SANDERLING VENTURE PARTNERS VI, L.P. | Venture Capital Fund | $310.2M | 72 | PRICEWATERHOUSECOOPERS |
| SANDERLING VENTURE PARTNERS VI, L.P. | Venture Capital Fund | $289.8M | 72 | KPMG LLP |
| SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $172.1M | 62 | PRICEWATERHOUSECOOPERS |
| SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $166M | 62 | ROTHSTEIN KASS |
| SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $132.8M | 62 | KPMG LLP |
| SANDERLING VENTURE PARTNERS V, L.P. | Venture Capital Fund | $101M | 48 | ROTHSTEIN KASS |
| SANDERLING VENTURE PARTNERS V, L.P. | Venture Capital Fund | $91.4M | 48 | KPMG LLP |
| SANDERLING VENTURE PARTNERS V, L.P. | Venture Capital Fund | $89.8M | 48 | PRICEWATERHOUSECOOPERS |
| SANDERLING VENTURES VII, L.P. | Venture Capital Fund | $88.7M | 30 | MOSS ADAMS LLP |
| SANDERLING V STRATEGIC EXIT FUND, L.P. | Venture Capital Fund | $71.4M | 10 | KPMG LLP |
| SANDERLING VENTURE PARTNERS V CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $57.9M | 30 | PRICEWATERHOUSECOOPERS |
| SANDERLING VENTURE PARTNERS V CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $49.6M | 30 | ROTHSTEIN KASS |
| SANDERLING V STRATEGIC EXIT FUND, L.P. | Venture Capital Fund | $49.3M | 10 | ROTHSTEIN KASS |
| SANDERLING VENTURE PARTNERS V CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $43.2M | 30 | KPMG LLP |
| SANDERLING V STRATEGIC EXIT FUND, L.P. | Venture Capital Fund | $40.9M | 10 | PRICEWATERHOUSECOOPERS |
| SANDERLING V BIOMEDICAL CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $35.2M | 5 | PRICEWATERHOUSECOOPERS |
| SANDERLING V BIOMEDICAL CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $30.5M | 5 | ROTHSTEIN KASS |
| SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $27.8M | 63 | MOSS ADAMS LLP |
| SANDERLING V BIOMEDICAL CO-INVESTMENT FUND, L.P. | Venture Capital Fund | $26.6M | 5 | KPMG LLP |
| SANDERLING V BIOMEDICAL, LP | Venture Capital Fund | $24.5M | 5 | ROTHSTEIN KASS |
| SANDERLING VENTURES VII, L.P. | Venture Capital Fund | $23.5M | 29 | KPMG LLP |
| SANDERLING V BIOMEDICAL, LP | Venture Capital Fund | $22.5M | 5 | KPMG LLP |
| SANDERLING VENTURES VII (CANADA), L.P. | Venture Capital Fund | $21.9M | 3 | MOSS ADAMS LLP |
| SANDERLING V BIOMEDICAL, LP | Venture Capital Fund | $21.8M | 5 | PRICEWATERHOUSECOOPERS |
Fund NameSANDERLING VENTURE PARTNERS VI, L.P.
TypeVenture Capital Fund
GAV$314.3M
Investors72
AuditorROTHSTEIN KASS
Fund NameSANDERLING VENTURE PARTNERS VI, L.P.
TypeVenture Capital Fund
GAV$310.2M
Investors72
AuditorPRICEWATERHOUSECOOPERS
Fund NameSANDERLING VENTURE PARTNERS VI, L.P.
TypeVenture Capital Fund
GAV$289.8M
Investors72
AuditorKPMG LLP
TypeVenture Capital Fund
GAV$172.1M
Investors62
AuditorPRICEWATERHOUSECOOPERS
TypeVenture Capital Fund
GAV$166M
Investors62
AuditorROTHSTEIN KASS
TypeVenture Capital Fund
GAV$132.8M
Investors62
AuditorKPMG LLP
Fund NameSANDERLING VENTURE PARTNERS V, L.P.
TypeVenture Capital Fund
GAV$101M
Investors48
AuditorROTHSTEIN KASS
Fund NameSANDERLING VENTURE PARTNERS V, L.P.
TypeVenture Capital Fund
GAV$91.4M
Investors48
AuditorKPMG LLP
Fund NameSANDERLING VENTURE PARTNERS V, L.P.
TypeVenture Capital Fund
GAV$89.8M
Investors48
AuditorPRICEWATERHOUSECOOPERS
Fund NameSANDERLING VENTURES VII, L.P.
TypeVenture Capital Fund
GAV$88.7M
Investors30
AuditorMOSS ADAMS LLP
TypeVenture Capital Fund
GAV$71.4M
Investors10
AuditorKPMG LLP
TypeVenture Capital Fund
GAV$57.9M
Investors30
AuditorPRICEWATERHOUSECOOPERS
TypeVenture Capital Fund
GAV$49.6M
Investors30
AuditorROTHSTEIN KASS
TypeVenture Capital Fund
GAV$49.3M
Investors10
AuditorROTHSTEIN KASS
TypeVenture Capital Fund
GAV$43.2M
Investors30
AuditorKPMG LLP
TypeVenture Capital Fund
GAV$40.9M
Investors10
AuditorPRICEWATERHOUSECOOPERS
TypeVenture Capital Fund
GAV$35.2M
Investors5
AuditorPRICEWATERHOUSECOOPERS
TypeVenture Capital Fund
GAV$30.5M
Investors5
AuditorROTHSTEIN KASS
TypeVenture Capital Fund
GAV$27.8M
Investors63
AuditorMOSS ADAMS LLP
TypeVenture Capital Fund
GAV$26.6M
Investors5
AuditorKPMG LLP
Fund NameSANDERLING V BIOMEDICAL, LP
TypeVenture Capital Fund
GAV$24.5M
Investors5
AuditorROTHSTEIN KASS
TypeVenture Capital Fund
GAV$21.9M
Investors3
AuditorMOSS ADAMS LLP
Fund NameSANDERLING V BIOMEDICAL, LP
TypeVenture Capital Fund
GAV$21.8M
Investors5
AuditorPRICEWATERHOUSECOOPERS